Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies

Induction of broadly neutralising antibodies (bnAbs) capable of inhibiting infection with diverse variants of human immunodeficiency virus type 1 (HIV-1) is a key, as-yet-unachieved goal of prophylactic HIV-1 vaccine strategies. However some HIV-infected individuals develop bnAbs after ~2-4 years of...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Borrow, P, Moody, M
Formatua: Journal article
Argitaratua: Wiley 2017